Skip to main content
. Author manuscript; available in PMC: 2011 Sep 14.
Published in final edited form as: Circulation. 2010 Sep 14;122(11 Suppl):S201–S208. doi: 10.1161/CIRCULATIONAHA.110.951178

Table 3. Between-Groups Comparisons of Pre- and Postoperative Findings.

Preoperative 6-Month Postoperative Change from Pre- to 6-Month Postoperative
Variable PVR Alone (N = 34) PVR with RV Remodeling (N = 30) PVR Alone (N = 32) PVR with RV Remodeling (N = 28) PVR Alone (N = 34) PVR with RV Remodeling (N = 30)
Cardiac Magnetic Resonance
 RV ejection fraction (%) 46 ± 9 48 ± 7 44 ± 9 47 ± 8 -2 ± 7 -1 ± 7
 Pulmonary regurgitation (%) 49 ± 12 50 ± 9 4 ± 5 6 ± 11 -25 ± 24 -31 ± 22
 RV end-diastolic volume index (ml/m2) 199± 34 202 ± 41 126 ± 26 119 ± 25 -68 ± 37 -78 ± 46
 RV end-systolic volume index (ml/m2) 108 ± 29 105 ± 29 72 ± 26 64 ± 21 -33 ± 23 -39 ± 26
 RV stroke volume (ml) 153 ± 41 158 ± 37 91 ± 21 95 ± 25 -57 ± 36 -58 ±36
 RV mass-to-volume ratio (g/ml) 0.22 ± 0.05 0.21 ± 0.04 0.25 ± 0.06 0.25 ± 0.05 0.03 ± 0.06 0.04 ± 0.05
 LV end-diastolic volume index (ml/m2) 92 ± 16 85 ± 15 95 ± 16 92 ± 19 3 ± 11 6 ± 12
 LV end-systolic volume index (ml/m2) 40 ± 12 36 ± 9 43 ± 13 39 ± 11 3 ± 8 2 ± 8
 LV stroke volume (ml) 87 ± 21 81 ± 21 90 ± 20 91 ± 25 3 ± 13 9 ± 15
 LV ejection fraction (%) 57 ± 8 58 ± 7 56 ± 7 58 ± 7 -1 ± 5 0 ± 7
 LV mass-to-volume ratio (g/ml) 0.66 ± 0.11 0.66 ± 0.13 0.64 ± 0.11 0.61 ± 0.11 -0.01 ± 0.10 -0.05 ± 0.11
ECG
 QRS duration (ms) 161 (91 - 200) 150 (82 - 182) 161 (80 - 202) 142 (82 - 190) 0 (-20 - 49) -1 (-24 - 16)
 QRS dispersion (ms) 21 (9 - 54) 22 (9 - 49) 23 (12 - 40) 27 (17 - 40) 0 (-32 - 15) 0 (-32 - 14)
 Heart rate-corrected QT interval (ms) 450 (301 - 514) 455 (370 - 523) 461 (359 - 528) 460 (381 - 558) 0 (-96 - 162) 4 (-84 - 70)
 QT dispersion (ms) 51 (17 - 200) 51 (12 - 171) 45 (22 - 178) 62 (29 - 116) 0 (-119 - 64) 0 (-69 - 68)
 JT interval (ms) 264 (204 - 418) 285 (213 - 351) 254 (200 - 359) 275 (125 - 333) 0 (-172 - 48) 0 (-146 -56)
 JT dispersion (ms) 53 (13 - 195) 55 (18 - 200) 40 (27 - 172) 60 (34 - 114) 0 (-108 - 69) 0 (-102 - 49)
Exercise test
 Peak VO2 (ml/kg/min) 27.1 (7.8 - 47.2) 26.5 (9.8 - 41.4) 27.0 (9.7 - 47.7) 27.4 (10 - 43.9) 0.0 (-8.6 - 6.1) 0.0 (-10.6 - 8.7)
 % predicted peak VO2 (%) 66 (26 - 93) 62 (42 - 101) 69 (30 - 95) 68 (41 - 95) -1 (-11 - 18) 1 (-25 - 25)
 % predicted peak work rate 71 (14 - 102) 70 (34 - 106) 77 (42 - 108) 78 (30 - 122) 0 (-8 - 27) 1 (-9 - 25)
 VAT (ml/kg/min) 16.0 (8.0 - 28.8) 14.5 (6.9 - 26.9) 14.7 (7.1 - 21.9) 15.4 (5.9 - 23.7) 0.0 (-11.1 - 4.8) 0.8 (-11.5 - 7.1)
 % predicted VO2 at VAT 39 (27 - 65) 38 (22 - 58) 37 (22 - 53) 38 (23 - 56) 0 (-24 - 14) 1 (-23 - 18)
 Peak heart rate (beats/min) 165 (106 - 208) 153 (87 - 193) 168 (110 - 201) 156 (100 - 194) 0 (-31 - 35) 1 (-67 - 103)
 % predicted peak heart rate 92 (65 - 111) 83 (59 - 123) 92 (68 - 109) 89 (56 - 128) 1 (-20 - 18) 2 (-42 - 69)
Echocardiogram
 ≤mild tricuspid regurgitation, % 91 82 100 96
 ≥moderate tricuspid regurgitation, % 9 18 0 4
 RV systolic pressure by tricuspid regurgitation (mm Hg) 37 (20 - 76) 30 (16 - 52) 26 (20 - 57) 25 (14 - 56) 0 (-38 - 3) 0 (-21 - 11)
 RVOT gradient (mm Hg) 20 (3 - 70) 13 (3 - 45) 12 (6 - 34) 15 (6 - 40) -2 (-60 - 24) 0 (-12 - 8)
Functional status
 SF-36 physical component 48.7 ± 9.1 49.9 ± 7.3 53.6 ± 7.1 56.0 ± 2.6 5 ± 9 6 ± 6
 SF-36 mental component 50.0 ± 7.7 49.1 ± 11.4 53.7 ± 6.8 55.4 ± 7.7 3 ± 6 6 ± 10
 CHQ-PF50 physical component 43.2 ± 13.9 41.2 ± 14.6 50.4 ± 9.7 52.4 ± 4.6 7 ± 11 10 ± 14
 CHQ-PF50 mental component 49.8 ± 10.2 49.6 ± 7.0 50.0 ± 10.5 54.5 ± 4.5 0 ± 9 4 ± 4

Data presented as median (range) or mean ± SD, as appropriate. Changes from pre- to 6-month postoperative were calculated carrying forward baseline values of those who failed to return for 6-month follow-up

In the PVR alone group, 4 patients decreased from ≥ moderate regurgitation to ≤ mild regurgitation

In the PVR with RV remodeling group, 3 patients decreased from ≥ moderate regurgitation to ≤ mild regurgitation.

VAT= ventilatory anaerobic threshold; VO2= oxygen consumption